William L. Delaat

Part of Merck & Co., Inc., Merck Sharp & Dohme (Australia) Pty Ltd. is an Australian research-intensive biopharmaceutical company committed to saving and improving lives. The company is based in North Ryde, Australia and is dedicated to following the science to tackle some of the world's greatest health threats. MSD Australia has a long legacy of research in infectious disease and has been mobilizing its scientific expertise and experience to develop an effective response to the COVID-19 pandemic since it was first recognized.

Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia.

Pharmaceuticals Industry Council was a non-profit organisation. The company has been forum for developing, evaluating and providing expert advice to government on issues affecting the Australian pharmaceuticals industry. It brought together senior executives from companies and peak bodies representing three industry sectors, including the research-based and generic medicines sectors and the biotechnology sector. The company was founded in 2006 and is headquartered in Deakin, the United Kingdom.

Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia.

EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia.

The George Institute for Global Health provides research and development for international health. It develops tools to empower people to improve their own health. The firm also uses mobile technology to make healthcare accessible worldwide and improves outcomes among stroke survivors. It helps preventing complications of diabetes. The company was founded by Stephen MacMahon and Robyn Norton in 1999 and is headquartered in Sydney, Australia.